• Gien L, Kwon J, Oliver T, Fung-Kee-Fung M, Gynecology Cancer Disease Site Group. Adjuvant hormonal therapy for stage 1 endometrial cancer: recommendations. Toronto (ON): Cancer Care Ontario (CCO); 2007 Oct 25. 19 p. (Evidence-based series; no. 4-14). [18 references]

The use of hormone therapy is not recommended as adjuvant treatment for patients with stage I endometrial cancer. The available evidence does not demonstrate any benefit with adjuvant hormone therapy.

None provided

The recommendations are supported by randomized controlled trials and meta-analyses.

• Gien L, Kwon J, Oliver T, Fung-Kee-Fung M, Gynecology Cancer Disease Site Group. Adjuvant hormonal therapy for stage 1 endometrial cancer: recommendations. Toronto (ON): Cancer Care Ontario (CCO); 2007 Oct 25. 19 p. (Evidence-based series; no. 4-14). [18 references]

Not applicable: The guideline was not adapted from another source.

2007 Oct

Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]

The Program in Evidence-based Care (PEBC) is a Province of Ontario initiative sponsored by Cancer Care Ontario and the Ontario Ministry of Health and Long-Term Care.

Cancer Care Ontario
Ontario Ministry of Health and Long-Term Care

Gynecology Cancer Disease Site Group

Members of the Gynecology Disease Site Group (DSG) were asked to disclose potential conflict of interest information. No conflicts were reported.

The following is available:

• Browman GP, Levine MN, Mohide EA, Hayward RSA, Pritchard KI, Gafni A, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13(2):502-12.

None available

This summary was completed by ECRI Institute on April 8, 2008.